Synthesis and pharmacological characterization of UVI3502, a novel cannabinoid receptor 1 (CB1) antagonist/inverse agonist
Preprint in bioRxiv (June 2024)
The most recent citing publications are shown below. View all 186 publications that cite this research output on Dimensions.
Preprint in bioRxiv (June 2024)
Article in Expert Review of Endocrinology & Metabolism (April 2024)
Article in Frontiers in Endocrinology (April 2024)